UPDATE: Duncan-Williams Color on Forest Laboratories PT Increase

Loading...
Loading...
Duncan-Williams, which
raised its PT
on shares of Forest Laboratories Inc.
FRX
, is providing some color on the stock. “In a recent SEC filing Forest disclosed that the Icahn parties held 7.20% of the outstanding common stock (fourth largest shareholder behind Wellington, Vanguard, and BlackRock),” Duncan-Williams writes. “We are hopeful that Mr. Icahn's involvement could result in initiatives such as bigger accretive deals using a levered balance sheet, divestiture of non-core assets accompanied by increased operational efficiencies, or cash returns to shareholders. We think that Icahn's move is timely given the potential opportunity to install a new CEO from outside the company.” Forest Laboratories closed Wednesday at $39.98.
Market News and Data brought to you by Benzinga APIs
Posted In: Analyst ColorAnalyst RatingsDuncan-Williamsforest laboratoriesHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...